HEPA logo

Hepion Pharmaceuticals (HEPA) Company Overview

Profile

Full Name:

Hepion Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

February 10, 2014

Indexes:

Not included

Description:

Hepion Pharmaceuticals focuses on developing innovative treatments for liver diseases, particularly non-alcoholic steatohepatitis (NASH). The company uses advanced technology to create therapies that aim to improve liver health and reduce complications associated with these conditions, contributing to better patient outcomes.

Events Calendar

Earnings

Next earnings date:

May 21, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 11, 2023

Analyst ratings

Recent major analysts updates

Dec 7, 23 Brookline Capital
Hold
Feb 28, 22 Cantor Fitzgerald
Overweight
Nov 22, 19 Brookline Capital
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Hepion Pharmaceuticals?
  • Does Hepion Pharmaceuticals pay dividends?
  • What sector is Hepion Pharmaceuticals in?
  • What industry is Hepion Pharmaceuticals in?
  • What country is Hepion Pharmaceuticals based in?
  • When did Hepion Pharmaceuticals go public?
  • Is Hepion Pharmaceuticals in the S&P 500?
  • Is Hepion Pharmaceuticals in the NASDAQ 100?
  • Is Hepion Pharmaceuticals in the Dow Jones?
  • When was Hepion Pharmaceuticals's last earnings report?
  • When does Hepion Pharmaceuticals report earnings?
  • Should I buy Hepion Pharmaceuticals stock now?

What is the ticker symbol for Hepion Pharmaceuticals?

The ticker symbol for Hepion Pharmaceuticals is NASDAQ:HEPA

Does Hepion Pharmaceuticals pay dividends?

No, Hepion Pharmaceuticals does not pay dividends

What sector is Hepion Pharmaceuticals in?

Hepion Pharmaceuticals is in the Healthcare sector

What industry is Hepion Pharmaceuticals in?

Hepion Pharmaceuticals is in the Biotechnology industry

What country is Hepion Pharmaceuticals based in?

Hepion Pharmaceuticals is headquartered in United States

When did Hepion Pharmaceuticals go public?

Hepion Pharmaceuticals's initial public offering (IPO) was on February 10, 2014

Is Hepion Pharmaceuticals in the S&P 500?

No, Hepion Pharmaceuticals is not included in the S&P 500 index

Is Hepion Pharmaceuticals in the NASDAQ 100?

No, Hepion Pharmaceuticals is not included in the NASDAQ 100 index

Is Hepion Pharmaceuticals in the Dow Jones?

No, Hepion Pharmaceuticals is not included in the Dow Jones index

When was Hepion Pharmaceuticals's last earnings report?

Hepion Pharmaceuticals's most recent earnings report was on Nov 14, 2024

When does Hepion Pharmaceuticals report earnings?

The next expected earnings date for Hepion Pharmaceuticals is May 21, 2025

Should I buy Hepion Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions